Halving the price of bionic prostheses and artificial organs



Hélice is an innovative financial engineering based on Blockchain that aims to halve the price of bionic prosthetics and artificial organs.

These technologies include retinal implants, prosthetic arms, neuroprosthetics, artificial hearts, exoskeletons etc.

We are frustrated by the exorbitant prices of these technologies ( ≈$100,000) and the slow pace of development in these fields.

The highly personalized nature of these devices complicates mass production, driving up prices.

Furthermore, biotechs struggle to advance innovation, as it can take them up to 10 years to generate revenue, resulting in low investments in this sector. 

This is where Hélice’s engineering comes into play. Firstly, by breaking the vicious cycle through halving prices, and secondly, by generating a capital influx to accelerate the development of these technologies within our future laboratory

How is the Halving accomplished ?*

*A French version is also available here

A first patient in 2021

Although the token is not yet in circulation, Dylan had the opportunity to be the first patient to benefit from the Hélice program. He was seeking funds to acquire the most advanced knee prosthesis available, the Genium x3, which costs €107,000. Hélice intervened to assist him by offering some tokens to individuals willing to contribute funds. These individuals will have access to the tokens upon the token launch.


Max Supply of 1 Unit

$HELICE is very rare and deflationary due to its max supply of 1 unit. We believe that the high value of the token (which will be equal to its Market Cap) will be a symbol of the project’s quality and enhance the reputation of our brand focused on the most advanced biotechnologies. Indeed, it would be devalued if the token had a value of $0.00… We believe that a perceived high value will attract more long-term investors as well as excellent partners to propel our growth.


Taxes and passive income.


To finance the prostheses, Hélice applies a 2.9% tax on its token (buy/sell). Additionally a tax of 1.3% (buy/sell) will be redistributed as a passive income to investors who hold theirs tokens. 

Buyback & Burn


The quantity of $HELICE will further decrease overtime, thanks to the buyback & burn initiated with each prosthetic sold.




First patient : Dylan

Additional partnerships


First halving and first buyback & burn 


More than 100 patients fitted with the most advanced prostheses


Creation of the Hélice model

Presentation to the community 


Token available 


First milestone (Not disclosed)


Creation of an R&D laboratory with our partners



Creation of the Hélice Model

First patient : Dylan

Presentation to the community 


Additional partnerships


Token available 


First halving and first buyback-burn


More than 100 patients fitted with the most advanced prostheses


First milestone (not disclosed at this stage)


Creation of an R&D laboratory with partners


Advisors & Team (non exhaustive)

Bernard Verrier | Ph.D in Biology

 Director of the “Tissue Biology and Therapeutic Engineering” department at the IBCP (CNRS & University of Lyon).

Born in France in 1957 and trained as a chemist, before getting a phD in molecular virology in 1985 and post-doctorated for three years at the EMBL, Germany, in retroviral oncology. Then, he moved to Lyon (France) to study human retrovirology, designing HIV vaccine candidates, either therapeutic, using tat,rev or nef regulatory proteins or prophylactic, with gp140 constructs, through a permanent position at CNRS. Director of research from CNRS since 2004, he was head of a joint unit between CNRS and bioMerieux, dedicated to HIV and HCV therapeutic vaccines.

Anton Sindali | Doctor of Medecine

Doctor of Medicine thesis (hepatic surgery).
Diplomas of 3rd cycles of university studies in Marseille (Aix- Marseille II): Qualified in General Surgery, University Diploma in Anaesthesia – Intensive Care, University Diploma in Pathological Anatomy, University Diploma in Abdominal Ultrasound, University Diploma in Digestive Endoscopy.
Diplomas of 3rd cycles of university studies in Paris (Paris XI): University Diploma in Laparoscopic Abdominal Surgery (Paris School of Surgery, Kremlin-Bicètre), University Diploma in Clinical Oncology Villejuif (IGR).


Denis Chriqui | Ph.D in Economics

Economist and former professional trader. After a Ph.D in economics from the University of Montpellier and training at the Wharton School, Denis was for more than 16 years a business buyer, professor of economics, specialist and researcher in behavioral finance, trainer in technical analysis and director of an import-export company. He worked as a professional trader in New York at Herzog Heine Geduld (Merrill Lynch) and E Trade for more than 6 years as an arbitrageur-strategist on derivatives, then in portfolio management and front office manager. Since 2004, Denis has been devoting himself to his vocation for teaching and proprietary trading.

Thierry Monmasson | Ph.D In Pharmaceutical Sciences

1993: Pharmacist Diploma: six-year university degree in industrial pharmacy with honors at the University of Pharmacy of Marseille. 1998: Master degree in Sciences, speciality Biochemistry and genetics at the University of medecine of Marseille. 1999: Diplôme d’études approfondies: one-year degree before postgraduate studies in cellular and molecular biology at the University of medecine of Marseille.
RESEARCH : Study of chaperone proteins and thyroid hormonegenesis, contribution to the study of the action of the disulfide isomerase protein in the thyroglobulin metabolism. 

Olivier Rousselle | Ph.D In Quantum Physics

Passionate by science and by the universe, Olivier has obtained a PhD in quantum physics at Sorbonne Université in 2022. He has dealt with different research topics until now: particle physics and software development at CERN; foundations of quantum physics at ENS; modeling and statistics at CNRS; biology and environmental studies at AgroParisTech. Moreover, he is passionate about the crypto / blockchain ecosystem, and he is currently involved in the development of efficient crypto algorithmic bots.

Curriculum : PhD in Physics at Sorbonne Université (2019-2022).

Master in Theoretical Physics at Aix-Marseille Université (2018-2019).

Engineer School AgroParisTech (2013-2017).

Florian Ravaz | Ph.D in Law

2007-2010 : Law degree (University of Toulon)

2010-2011 : Master of Law, Mention public law and private law (University of Toulon)

2011-2012 : Master of Notarial Law (University of Toulon).

2012-2016 : PhD in public law on “Taxation of non -resident foreigners in France”, very honorable mention (University of Toulon).

Jaime Lourenço | Ph.D in Economics

Samuel G. Ongala-Eedoumou I MSc In Physics

Master’s Degree – Magnetic Fusion Confinement Université Pierre et Marie Curie (Paris VI) 2012 – 2015

Diploma in Basic Physics International Center for Theoretical Physics Trieste, Italy 2011 – 2012

Maitrise de Physique Université Marien Ngouabi Congo 2009 – 2010

Licence de Physique Université Marien Ngouabi Congo 2008 – 2009

Adrien Marchand | MSc In International Finance

ESM IAE Metz Master 2, International Finance · (2017 – 2018)

Saint Petersburg State University of Economics. Master 1 International Management · (2016 – 2017)

Université d’Angers – Bachelor of Science in Economics and International management · (2015 – 2016).

Lucas Ewig I Master in Management & MSc Corporate Financial Management

Master in Management & MSc Corporate Financial Management
SKEMA Business School – 2022
-Blockchain & Cryptocurrencies
-Corporate Finance & Financial Markets

Bachelor’s degree in Economics and Management – Faculty of Economics and Management of Strasbourg – 2019
(top 3% of promotion)

Jérôme Sohier | Ph.D in Biomedical engineering

Researcher at the « Tissue Biology and Therapeutic Engineering » department at the IBCP (CNRS & University of Lyon).

Born in France in 1976 and trained as a polymer chemist, Dr. Sohier was a junior researcher in the first European tissue engineering company (IsoTis) prior to obtaining a Ph.D. in biomedical engineering from the university of Twente (Netherlands) in 2006. He then continued his studies and developments of regenerative medicine strategies in post-doctoral appointments in Nantes (Lab. of osteoarticular and dental engineering INSERM) and London (Imperial College, National Heart and Lung Institute). He has a strong interest in translating his research to patients needs and had the opportunity of participating in the creation of a startup company dedicated to bone repair, based on an innovative technology that he invented.  Since 2012, he is a permanent researcher in Lyon, where he continues to develop translatable approaches to repair and regenerate various tissues, for which there are no therapeutic alternatives.

Mickaël LEB | MSc Financial Markets and Investments & Master en Management

Passionate about finance, economics and geopolitics, Mickael graduated with a double degree in Finance and Management.

Since 2018, he developed his expertise in the investment management and advisory industry through his international experiences in Asset Management and Wealth Management among global industry top players.

Mickael is currently the Head of Sales in a world leading Private Bank.

His interest in the blockchain ecosystem as well as his exposure to cryptocurrency investments led him to become an Advisor at Hélice.

Zackary E. | Marketing Advisor

William Kabaz I Master in International Management

Seasoned expert in digital asset management, holds a Bachelor’s degree in Economics and Finance from ASSAS Paris-II and a Master’s from NEOMA Business School. He has over three years of hands-on experience in managing private cryptocurrency funds and day trading. His familiarity with DeFi and Web 3 protocols, coupled with his strong background in economics and finance, has been instrumental in his strategic approach to investment.

Héloïse Ravaz | Founder and CEO

And that’s not all ! 

Hélice works closely with over a dozen other experts, including scientists, researchers, economists, traders, physicists, engineers, lawyers, and more….

Bernard Verrier | Ph.D In Biology

Anton Sindali | Surgeon

Denis Chriqui | Ph.D In Economics

Thierry Monmasson | Ph.D In Pharmaceutical Sciences

Olivier Rousselle | Ph.D In Quantum Physics

Florian Ravaz | Ph.D In Law

Jaime Lourenço | Ph.D In Economics

Héloïse Ravaz | Founder & CEO Of Hélice

Samuel G. Ongala-Eedoumou I MSc In Physics

Adrien Marchand | MSc In International Finance

Lucas Ewig I Master in management / MSc in corporate financial management

In the Press

  NFT whitelist (limited offer) :


    9A Boulevard de Strasbourg 83000 Toulon, France